Chronic Kidney Disease on the Background of Bardet-Biedl Syndrome: a Case Report and Review of Literature
An 18-year-old male presented to the emergency department with chief complaints of fever, cough, vomiting, and decreased urine output for 7 days. Parents complained that the child had a delay...
The management of chronic kidney disease in the background of Bardet-Biedl syndrome poses unique challenges due to the complex multisystem involvement of this genetic disorder.
Share
Evaluation of Health-Related Quality of Life in Adolescents With Obesity: a Randomized Qualitative Study Among Healthcare Professionals
Adolescent obesity constitutes a disorder with physical and psychosocial implications. Childhood and adolescent obesity rates are constantly increasing worldwide. Since adolescent obesity is a chronic disease, which is part of...
Researchers identified that a structured tool implementation to assess health-related quality of life in daily clinical routine is an unmet need for pediatricians treating adolescents with obesity.
Share
Exploring the Comorbidity Mechanisms Between Psoriasis and Obesity Based on Bioinformatics
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10818127/
Psoriasis is a chronic, recurrent, immune‐mediated inflammatory skin disease characterized by erythematous scaly lesions. Obesity is currently a major global health concern, increasing the risk of diseases such as cardiovascular...
Psoriasis and obesity may mutually influence each other through multiple targets and pathways, emphasizing the importance of considering comorbidity treatment and daily care in clinical practice.
Share
Obesity/Cardiometabolic Phenotype of Heart Failure With Persevered Ejection Fraction: Mechanisms to Recent Trials
Source : https://pubmed.ncbi.nlm.nih.gov/38294186/
The obesity phenotype of HFpEF is seen in upward of 80% with HFpEF. Obesity is not just a bystander, but plays an essential role in the pathobiology and clinical course...
Emerging data suggest that inflammatory biomarkers, specifically, interleukin 6, may provide useful information about heart failure with preserved ejection fraction severity and symptom burden in obesity.
Share
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: an Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58464 Patients With Atrial Fibrillat
Source : https://pubmed.ncbi.nlm.nih.gov/38264923/
The treatment effect of NOAC versus warfarin in atrial fibrillation is generally consistent for stroke/SEE across the spectrum of BMI and BW, whereas the reduction in major bleeding is attenuated...
The treatment effect of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation is generally consistent for stroke across the spectrum of BMI and body weight, whereas the reduction in major bleeding is attenuated at a higher BMI and body weight.
Share